| ²é¿´: 653 | »Ø¸´: 1 | ||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷ÕßµãµãÓðÂ佫ÔùËÍÄú 50 ¸ö½ð±Ò | ||
µãµãÓðÂä½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
¼±ÇóSASͳ¼Æ´óÉñ
|
|
|
SCIÎÄÕ¶þÉó£¬ÓÐûÓÐͳ¼Æ´óÉñ°¡£¬¶þÉóÆäÖÐÎÊÌ⣺ÔÚ2.5 Statistical analysis£ºÐè˵Ã÷SASͳ¼ÆÄ£Ê½°üÀ¨ÄÄЩÏîÄ¿£¿ÒÔ¼°·½²î·ÖÎöÓ°ÏìÏÔÖøÊ±£¬ÓÃɶ·½·¨½øÐи÷´¦ÀíÆ½¾ùÊý¼äµÄ²îÒìÏÔÖøÐÔ¼ìÑ飿 ֮ǰÎÒдµÄ 2.5 Statistical analysis The treatment effects were assessed by the GLM procedure of ANOVA (version 9.4, SAS inst, Inc., Cary, NC), where pen was the statistical unit. The linear and quadratic effects of saccharicterpenin level were assessed using orthogonal polynomials. P < 0.05 was used as the criterion for statistical significance. ÎÒÐèÒªÔõôÐ޸ĸ÷λ´óÉñ°ï°ïæ¡£ |
» ²ÂÄãϲ»¶
2026Äê8ÔÂ25ÈÕ¹ú×ÔÈ»·Å°ñǰͻȻÊÕµ½ÁÐÈëÆÀÉóר¼ÒÓʼþ£¬ÓйØÏµÂð£¿
ÒѾÓÐ22È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.551.O.5.4,¿ÆÄ¿È«,¿ÉÙ¤¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.5.4,¿ÆÄ¿È«,¿É+¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.5.4,¿ÆÄ¿È«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8O.55.1.O.5.4,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
½ñÌìÎñί»á¿ªÍêÁË£¬Ã÷Ìì³ö½á¹ûÂð
ÒѾÓÐ22È˻ظ´
ÔÚ¼á±ù»¹¸Ç×ű±º£µÄʱºò£¬ÎÒ¿´µ½ÁËŷŵÄ÷»¨¡£
ÒѾÓÐ9È˻ظ´
Ã÷ÌìÓ¦¸Ã¿É²éÁË£¡£¿
ÒѾÓÐ6È˻ظ´
ÓÐûÓдóÉñ°ïÎÒ¿´¿´»ù½ð´úÂë
ÒѾÓÐ10È˻ظ´
·Å°ñǰµÄ²»µ¶¨
ÒѾÓÐ19È˻ظ´

µãµãÓðÂä
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1044.9
- É¢½ð: 76
- ºì»¨: 4
- ɳ·¢: 1
- Ìû×Ó: 706
- ÔÚÏß: 84.8Сʱ
- ³æºÅ: 7115343
- ×¢²á: 2017-08-29
- רҵ: ÐóÄÁѧ

2Â¥2019-04-04 15:17:33









»Ø¸´´ËÂ¥
28